COLLABORATIVE MODEL

The training shall provide participants with the opportunity to attain competence, understanding, and the requisite skills for the creation of the appropriate set and setting for KAP. This includes learning the therapeutic modalities and tools necessary for guiding patients who are in non-ordinary states of consciousness.

The program will teach a collaborative model that leverages the core competencies of multiple healing disciplines to maximize the therapeutic and personal developmental benefits of this approach. Thus, the program will teach its participants how to work in teams that may combine medical psychological and pastoral practitioners, in which the patient receives both the best possible medical and psychological care and understanding. Team formation will be facilitated by KTC based on the settings and therapeutic objectives of participants.

DIRECT EXPERIENCE OF FACILITATED KETAMINE THERAPY

KTC believes that experiential learning is an essential part of KAP training to ensure that those who will deliver this service have had personal experience with this medicine in the context of a collaborative therapeutic practice. Since KAP fosters a unique non-ordinary mind state that is generative of therapeutic change and development, it is an imperative to have had real time experience with ketamine–under similar conditions as those offered to patients. This teaches the nature and power of the ketamine experience enabling a skillful, aware, compassionate and empathetic understanding of patients’ experiences. All participants with be expected to participate in this experiential learning.

Workshop participants will have the experience of two methods of medication delivery: the oral lozenge and intramuscular injection (IM). In an ascending order of intensity and appropriately administered based on assessment of effect for each individual. Participants will be guided and cared for–providing real time experience in the administration of ketamine, with facilitation of skills during dyadic sessions, as well as post session work to foster integration of the experiences.

Each KAP team will determine the role and responsibilities of its members, with licensed medical practitioners always responsible for prescription and delivery of the medication itself under Schedule 3 practice guidelines. Each team will make use of its unique professional resources to determine the protocols that will work best for its collaborative efforts. All KTC graduates will have had a direct experience of the arc of treatment, from diagnosis and administration of the medicine through the processing and integration of the experiences.

FUTURE MENTORING, INDIVIDUAL SUPERVISION AND PROFESSIONAL DEVELOPMENT

There will be follow up internet hosted virtual meetings for each training cohort at 2-6 weeks after the workshop. Participants will be able to share with the group their personal and clinical experiences and bring their inquiries for elucidation, supervision and feedback.

Although it is not a requirement of KTC that participants follow up with the trainers or share data, KTC encourages all graduates to confidentially and anonymously share their findings. KTC provides vigorous support to the community practicing KAP and looks forward to participants’ future contributions to this important emerging field.

In this regard The Ketamine Research Foundation has created a program to further collaboration, development of local practices, the sharing of clinical information, practitioner concerns and the provision of support through an expanding international organization—Ketamine Psychotherapy Associates. Benefits of KPA membership are evolving and include:

• Monthly live zoom consultation sessions
• Access to care for Patients who cannot afford full fees
• Library: full privileges to our complete collection of ketamine human studies with Full-Text articles
• Our Referral list and electronic badge–developed with Search Engine Optimization for access by potential patients throughout the US and Canada.
• Participation in design and execution of KRF research programs.
• Participation in our Annual Retreat
• Access to our Leadership Group for ongoing consultation
• The Redcap digital data and charting system in collaboration with Vanderbilt University—we are developing publications that will include your data as part of the demonstration of KAPs benefits.
• Participation in the range of Foundation programs
• An international marketing program for KAP and its local practices

We hope and urge that workshop participants will go on to participate in the data collection research arm of The Ketamine Foundation, namely The Ketamine Data Project (KDP).

Participants will have the option to arrange private consultations with any of the workshop leaders. These arrangements can be made individually with workshop leaders and are not covered in the scope of the workshop. The Center for Transformational Psychotherapy will be providing ongoing supervisorial sessions for those interested.

KTC will periodically present advanced workshops that will focus on particular topics relevant to KAP practice and for further training.

We hope that participants will share their KAP clinical experiences with other cohort members and the broader medical, psychological and hospice community after completing the training.

PUBLIC EDUCATION

Graduates of KTC training will be at the vanguard of this treatment modality. The Training Center and KRF will provide assistance to those who will seek to publish articles about KAP. We support KTC graduates in bringing cutting edge information to broader public awareness– stories about the powerful transformational power of Ketamine Assisted Psychotherapy. We look forward to bringing greater awareness of our interdisciplinary approach to the larger therapeutic community.

RESEARCH WITH KRF

KRF is involved in an increasingly broad range of research activities that span the possibilites of Ketamine’s use. KTC graduates are welcome to join in our work and to offer new concepts to KRF for research. We are continually developing strategies for the beneficial use of Ketamine.